| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.6M | +33.7% |
| R&D Expense | $4.0M | +183.3% |
| SG&A Expense | $12.9M | +21.9% |
| Operating Income | -$37.4M | -1230.7% |
| Interest Expense | $78K | -7.1% |
| Pre-tax Income | -$36.2M | -1143.1% |
| Income Tax | -$762K | -263.9% |
| Net Income | -$35.4M | -1348.4% |
| EPS (Basic) | -$1.54 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.5M | -26.7% |
| Accounts Receivable | $3.3M | +51.4% |
| Inventory | $679K | +193.9% |
| Current Assets | $12.3M | +6.8% |
| Total Assets | $55.6M | -27.9% |
| Current Liabilities | $10.4M | -1.7% |
| Long-term Debt | $3.0M | +61.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$411K | +59.1% |
| Capital Expenditures | $289K | +186.1% |
| Investing Cash Flow | -$1.7M | -362.0% |
| Financing Cash Flow | -$54K | +99.5% |
| Free Cash Flow | -$700K | +36.8% |
| -1183.3% |
| EPS (Diluted) | -$1.54 | -1183.3% |
| Total Liabilities |
| $14.2M |
| +26.3% |
| Stockholders' Equity | $41.5M | -37.1% |